Chief patent counsel and key dealmaker Micky Minhas announces his departure, while his former boss Erich Andersen is named as TikTok’s general counsel
In an exclusive interview, Fred Mau says launch of new licensing and tech transfer programme is part of a more proactive approach to technology and innovation outreach for the Japanese automaker
Homegrown smartphone firm increasingly targeted by licensors has upped its research output in recent years
The High Court of Delhi has taken inconsistent positions on issues of evergreening and genus/species patents in case that goes to heart of protections available to life sciences companies
A state-run telecom's claim to be producing its own networking gear is the latest indication that there are opportunities for IP-based collaboration in a fast growing tech market
After a record-breaking 2019, here are the key value-creation issues to look out for in the new decade
The award of $448 million in antitrust damages against the company in case brought by the Federal Trade Commission is also at stake.
Move by Parallax Health Sciences is an indication that patent assertion plays could increasingly affect life sciences companies as their use of digital technologies increases
Last year patent agencies came under scrutiny for gaming the system, and corporate IP managers say they expect tighter auditing in the year to come
But study by Chinese trade body shows that respondents who fight back do surprisingly well
A precedential decision last month makes it easier for rights holders to assert successfully against imported products
Nineteen companies in all took the chance to secure rights to the portfolio before a contingent of South Korean and Japanese patent owners departed the pool last Thursday
Previously unaffiliated, the Chinese company is set to come on board as a licensor and licensee
The California case was one of the early patent battles over the breakthrough cancer cell therapy technology, which is set to become a crowded space in years to come.
Arlington-based firm acts for more of the companies that own the biggest US portfolios than any other, with Foley & Lardner and Harness Dickey & Pierce rounding out the top three